Limited Use Note(s)

Government of Ontario Logo
SALMETEROL XINAFOATE & FLUTICASONE PROPIONATE50/500mcg Inh-60 Dose Pk
Reason For Use CodeClinical Criteria
330For the treatment of asthma in patients who are using optimum anti-inflammatory treatment and are still experiencing breakthrough symptoms.
LU Authorization Period: Indefinite.